Pharmagy ApS: Financial statements 2025
CVR: 41488514
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharmagy ApS (CVR 41488514) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,097,834 and a net result of DKK 966,279 compared with DKK 1,080,195 the year before. That is a decrease of 4% compared with the year before. Equity in the 2025 report amounted to DKK 3,553,305. The solvency ratio was 83%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,097,834
- Profit/Loss
- DKK 966,279
- Equity
- DKK 3,553,305
- Total Assets
- DKK 4,279,565
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 3.1M | 966K | 3.6M | 2 |
| 2024 | - | 3.2M | 1.1M | 2.8M | 2 |
| 2023 | - | 2.8M | 808K | 1.9M | 2 |
| 2022 | - | 2.7M | 731K | 1.3M | 2 |
Official annual report
How creditworthy is Pharmagy ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharmagy ApS has published its annual report for 2024. Gross profit came to DKK 3,225,687, and the net result was DKK 1,080,195.
About Pharmagy ApS
Pharmagy ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2020. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kirsten Bjerrum and Lars Bøndergaard. The company is owned by LKSynergy ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,097,834 and a net result of DKK 966,279 compared with DKK 1,080,195 the year before. Equity in the 2025 report amounted to DKK 3,553,305.